follow up the room does not treat closer as safer, and it took a few bad experiences to get us there, i have it written down somewhere
#asia 2026-01-18
Sunday19 messages5 participantstimes are UTC
Highlights from this day
- quiet_head_qi — follow up the room does not treat closer as safer, and it took a few bad experiences to get us there, i have it written down somewhere 22:24
- tokyo_taper — follow up japanese insurance covered the diabetes indication and not the weight one as far as anyone here could establish a year ago 22:28
- rotterdam_recon — a member in tokyo reported an out of pocket cost in the region of twenty thousand yen a month in 2024, at a clinic 22:30
- quiet_head_qi — india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every… 22:40
a korean member said their clinic visit took under an hour end to end, which is not a claim about the quality of the assessment
follow up japanese insurance covered the diabetes indication and not the weight one as far as anyone here could establish a year ago
a member in tokyo reported an out of pocket cost in the region of twenty thousand yen a month in 2024, at a clinic
😂5❤️6
is it covered by insurance anywhere in the region
insurance in the region tracked the diabetes indication in every country a member reported on
write it down for the pharmacy
india has a real generics manufacturing base and a real domestic market. what a specific product is, and whether it matches its label, is a separate question every single time
a member in hong kong and a member in singapore compared the same dose and came out about forty percent apart
the carrier matters
reported by members, own currency, not comparable directly
private clinic, UK 145 - 220
statutory, DE 10 co-pay
private script, DE 180 - 240
pharmacy, PL 95 - 140
pharmacy, SE 210 - 260korea has a clinic culture where this is straightforward to obtain, and members reported that as both a convenience and a concern
japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price
korea is fast
does anyone in hong kong want to compare prices
japan approved it
are the indian products the same compounds or something else entirely
a parcel of mine was held inside the region and released after 12 days with no letter and no charge, someone check my working
diabetes indication only
ok so korea and the clinic culture, is it as easy to get as people say